Humacyte Wins U.S. Patent Protecting Symvess Processes Through 2043

Humacyte received U.S. Patent No. 12,742,144 covering manufacturing, sterilization, storage and shipping methods for Symvess (ATEV) and other tissues, extending protection through 2043.